Stock SYNTHETIC BIOLOGICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Synthetic Biologics Inc Nyse

Equities

US87164U1025

Chart calendar Synthetic Biologics Inc

112f9de6.B91ZFwONm6ZudcwVVUn56U9tDE-rZQge83LIwWcfbV0.RIpodlH839wFNpleEAy_2nwbbhfcVnhdhiuPlgxpFypWih9cTO_pxVkmow~84c5deb3dc3b145703b6e587e5d46c56

Upcoming events on Synthetic Biologics Inc

2024-05-07 Q1 2024 Earnings Release (Projected)
2024-05-10 12:00 pm American Society of Gene & Cell Therapy Meeting - Abstract No: 1760
2024-06-01 02:30 pm American Society of Clinical Oncology Meeting - Abstract Number: TPS4210
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-02-26 Q4 2024 Earnings Release (Projected)

Past events on Synthetic Biologics Inc

2024-03-25 08:30 am Q4 2023 Earnings Call
2024-03-25 08:00 am Q4 2023 Earnings Release
2024-03-19 Benzinga Virtual Healthcare Summit
2024-03-18 10:00 am BioEurope Spring Conference
2024-01-18 09:30 am B. Riley Securities Oncology Conference - Fireside Chat
2023-12-06 03:10 pm Emerging Growth Conference
2023-11-13 08:30 am Q3 2023 Earnings Call
2023-11-13 08:00 am Q3 2023 Earnings Release
2023-11-07 05:15 am BIO Europe Conference
2023-11-02 12:00 am Emerging Growth Conference
2023-10-23 08:00 am Investor Meeting - Key Opinion Leader
2023-10-22 06:00 am European Society for Medical Oncology Congress
2023-10-05 09:40 am Emerging Growth Conference
2023-08-08 08:30 am Q2 2023 Earnings Call
2023-08-08 08:00 am Q2 2023 Earnings Release
2023-05-11 08:30 am Q1 2023 Earnings Call
2023-05-11 08:00 am Q1 2023 Earnings Release
2023-04-17 06:00 am European of Clinical Microbiology & Infectious Diseases Congress - Poster Number: (#P2280)
2023-03-30 08:30 am Q4 2022 Earnings Call
2023-03-30 08:00 am Q4 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-15,7
-16,3
3.92%		-10,2
-12,0
15.45%		-14,3
-12,4
-14.67%		-21,6
-19,7
-9.78%		-21,4
-21,9
2.13%
-28,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-10,1
-12,0
15.51%		-14,3
-12,4
-14.66%		-21,1
-19,6
-7.65%		-20,0
-21,4
6.78%
-28,6

Net income
Million USD		Released
Forecast
Spread 		-16,1
-16,9
4.87%		-12,6
-12,9
2.3%		-23,2
-12,4
-86.35%		-19,7
-19,6
-0.39%		-18,3
-21,4
14.43%
-28,6

EPS
USD		Released
Forecast
Spread 		-9,80
-10,3
4.85%		-6,60
-5,60
-17.86%		-1,90
-1,80
-5.56%		-1,31
-1,30
-0.77%		-1,14
-1,37
16.79%
-0,81

Announcement Date20/02/2004/03/2116/03/2230/03/2325/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-5,27
-3,44
-53.1%


-4,99
-4,80
-3.8%		-5,01
-6,42
21.96%		-7,33
-5,41
-35.55%		-5,18
-6,23
16.83%		-5,82
-5,47
-6.34%		-4,22
-6,40
34.11%		-6,22
-6,68
6.95%
-6,57


-6,86


-7,43


-7,72

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-5,26
-3,44
-53.04%


-4,97
-5,11
2.68%		-4,85
-5,35
9.27%		-7,02
-5,52
-27.22%		-4,81
-6,23
22.78%		-5,44
-5,70
4.44%		-3,83
-6,40
40.17%		-5,91
-7,36
19.74%
-6,57


-6,86


-7,43


-7,72

Net income
Million USD		Released
Forecast
Spread 		-5,26
-3,44
-53.04%


-4,97
-5,11
2.68%		-4,85
-5,35
9.27%		-5,59
-5,52
-1.38%		-4,48
-6,23
28.08%		-5,08
-5,70
10.74%		-3,30
-6,40
48.41%		-5,49
-7,36
25.5%
-6,57


-6,86


-7,43


-7,72

EPS
USD		Released
Forecast
Spread 		-0,40
-0,30
-33.33%


-0,31
-0,40
22.5%		-0,33
-0,34
2.94%		-0,36
-0,35
-2.86%		-0,30
-0,39
23.08%		-0,34
-0,38
10.53%		-0,19
-0,42
54.76%		-0,33
-0,49
32.65%
-0,19


-0,19


-0,21


-0,22

Announcement Date16/03/2216/05/2211/08/2210/11/2230/03/2311/05/2308/08/2313/11/2325/03/24----

Upcoming sector events for Synthetic Biologics Inc

2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 04:05 pm EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Synthetic Biologics Inc

2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 04:05 pm PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
  1. Stock Market
  2. Equities
  3. TOVX Stock
  4. Stock
  5. Calendar Synthetic Biologics Inc